risks of glp 1 medications Why do patients stop GLP-1 drugs? Is GLP-1 the Same as

10.3389/fphys.2021.619442 272 VilelaR

2.3 Experimental and clinical evidence The current research evidence covers many levels such as cellular models, animal studies, and clinical samples, suggesting that ferroptosis plays an important pathogenic role in kidney injury associated with DKD

Glutathione is a powerful antioxidant which performs a range of critical functions in the body

Summary: Researchers unmasked a slight, statistically measurable increase in the risk of developing a rare, potentially permanent blinding condition known as ischemic optic neuropathy (a sudden restriction of blood flow to the optic nerve) among patients initiating GLP-1 therapy compared to standard diabetes regimens